• 1. An assay for the enzyme N-acetyl-β-d-glucosaminidase (NAGase) based on electrochemical detection using screen-printed carbon electrodes (SPCEs)
  R. M. Pemberton,J. P. Hart,T. T. Mottram Analyst, 2001,126, 1866-1871
• 2. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 3. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170
• 4. Achieving crystal-induced room temperature phosphorescence and reversible photochromic properties by strong intermolecular interactions?
  Fuming Xiao,Mengzhu Wang,Yunxiang Lei,Wenbo Dai,Yunbing Zhou,Miaochang Liu,Wenxia Gao,Xiaobo Huang,Huayue Wu J. Mater. Chem. C, 2020,8, 17410-17416
• 5. An ionic liquid promoted microwave-hydrothermal route towards highly photoluminescent carbon dots for sensitive and selective detection of iron(iii)?
  Ruili Liu,Mengping Gao,Jing Zhang,Zhilian Li,Jinyang Chen,Ping Liu,Dongqing Wu RSC Adv., 2015,5, 24205-24209

Introduction to Tert-butyl 2-(2-hydroxycyclopentyl)piperidine-1-carboxylate (CAS No. 1559209-94-7)

Tert-butyl 2-(2-hydroxycyclopentyl)piperidine-1-carboxylate, identified by its Chemical Abstracts Service (CAS) number 1559209-94-7, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the piperidine class of heterocyclic amines, characterized by a six-membered ring containing one nitrogen atom. The presence of a tert-butyl group at the 1-position and a 2-hydroxycyclopentyl side chain introduces unique structural and functional properties, making it a promising candidate for various biochemical applications.

The tert-butyl 2-(2-hydroxycyclopentyl)piperidine-1-carboxylate molecule exhibits a high degree of steric hindrance due to the bulky tert-butyl moiety, which can influence its interactions with biological targets. This steric effect, combined with the hydroxyl group in the 2-hydroxycyclopentyl substituent, suggests potential applications in drug design, particularly in modulating enzyme activity and receptor binding. The compound’s structural features align well with the growing interest in biologically active molecules that incorporate cycloalkyl and piperidine motifs, which are known for their favorable pharmacokinetic profiles.

Recent advancements in computational chemistry and molecular modeling have enabled researchers to explore the binding affinities and mechanistic interactions of tert-butyl 2-(2-hydroxycyclopentyl)piperidine-1-carboxylate with various biological targets. Studies have indicated that this compound may exhibit inhibitory effects on certain enzymes implicated in metabolic disorders and inflammatory pathways. The hydroxyl group’s ability to form hydrogen bonds further enhances its potential as a pharmacophore, facilitating stable interactions with protein receptors. Such properties make it an attractive scaffold for developing novel therapeutic agents.

In the realm of drug discovery, the synthesis of derivatives of tert-butyl 2-(2-hydroxycyclopentyl)piperidine-1-carboxylate has been extensively explored. Researchers have modified its structure to optimize solubility, bioavailability, and target specificity. For instance, incorporating fluorine atoms or other electronegative groups into the hydroxycyclopentyl moiety has been shown to enhance metabolic stability and reduce off-target effects. These modifications align with current trends in medicinal chemistry, where designing molecules with minimal toxicity and maximal efficacy is paramount.

The role of tert-butyl 2-(2-hydroxycyclopentyl)piperidine-1-carboxylate in preclinical studies has also been noteworthy. Preliminary data suggest that this compound may serve as a lead compound for treating conditions such as neurodegenerative diseases and autoimmune disorders. Its ability to cross the blood-brain barrier and interact with central nervous system receptors makes it a candidate for developing treatments targeting neurological disorders. Additionally, its structural similarity to known bioactive compounds suggests potential synergistic effects when used in combination therapies.

From a synthetic chemistry perspective, the preparation of tert-butyl 2-(2-hydroxycyclopentyl)piperidine-1-carboxylate involves multi-step organic transformations, including nucleophilic substitution reactions, cyclization processes, and protective group strategies. The use of advanced catalytic systems has streamlined these synthetic routes, making large-scale production more feasible. This progress underscores the importance of robust synthetic methodologies in enabling the exploration of complex molecular architectures like those found in this compound.

The chemical properties of tert-butyl 2-(2-hydroxycyclopentyl)piperidine-1-carboxylate, such as its solubility profile and thermal stability, have been thoroughly characterized using spectroscopic techniques like nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS). These analyses provide critical insights into its molecular structure and purity, ensuring that it meets the stringent requirements for pharmaceutical applications. Furthermore, computational studies have helped predict its behavior under different conditions, aiding in the rational design of experiments.

As research continues to evolve, the applications of tert-butyl 2-(2-hydroxycyclopentyl)piperidine-1-carboxylate are expected to expand beyond traditional pharmaceutical uses. Its unique structural features make it a versatile building block for designing novel materials with applications in agrochemicals and specialty chemicals. Additionally, its potential as an intermediate in synthesizing complex natural products has not been fully exploited but holds promise for future investigations.

In conclusion,Tert-butyl 2-(2-hydroxycyclopentyl)piperidine-1-carboxyllate (CAS No. 1559209-94-7) represents a significant advancement in medicinal chemistry due to its innovative structure and multifaceted applications. Its role in drug discovery, coupled with ongoing research into its derivatives and mechanisms of action, positions it as a cornerstone compound for future therapeutic developments. As scientists continue to unravel its potential, this molecule is poised to make substantial contributions to both academic research and industrial applications.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)